Browsing by Author "Andreopoulou, E."
Now showing items 1-6 of 6
-
Article
Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: A hellenic cooperative oncology group study
Dimopoulos, M. A.; Papadopoulou, M.; Andreopoulou, E.; Papadimitriou, C.; Pavlidis, Nicholas; Aravantinos, Gerasimos; Aspropotamitis, A.; Anagnostopoulos, A.; Fountzilas, George; Michalas, S.; Pectasides, Dimitrios (1998)Purpose. To evaluate the outcome and the prognosis of patients with ovarian germ cell malignancies who were treated with platinum-based chemotherapy immediately after initial surgery. Methods. We conducted a retrospective ...
-
Article
G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant setting
Briassoulis, E. Ch; Andreopoulou, E.; Ch, F. Tolis; Bairaktari, Eleni Th; Katsaraki, A.; Dimopoulos, M. A.; Fountzilas, George; Seferiadis, C.; Pavlidis, Nicholas (2001)BACKGROUND. Cancer antigen 15-3 (CA 15-3), a circulating marker that determines secreted products of the polymorphic MUC1 gene, has been established as a convenient tool for monitoring breast carcinoma patients. METHODS. ...
-
Article
Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: A phase II study
Kosmidis, Paraskevas A.; Mylonakis, N.; Fountzilas, George; Samantas, E.; Athanasiades, A.; Andreopoulou, E.; Pavlidis, Nicholas; Skarlos, Dimosthenis V. (1997)Background: Based on the high activity of single-agent paclitaxel and the superior one-year survival rates of patients with non-small-cell lung cancer (NSCLC) treated with carboplatin, a phase II trial was initiated using ...
-
Article
Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: A clinicopathological comparison between tonsillar and non tonsillar lymphomas
Economopoulos, T.; Fountzilas, George; Kostourou, A.; Daniilidis, J.; Pavlidis, Nicholas; Andreopoulou, E.; Nicolaou, A.; Papageorgiou, E.; Mellou, S.; Dervenoulas, John; Stathakis, N. (1998)Primary extranodal NHL of the head and neck (HN-NHL) accounts for 10-20% of all cases of NHL. Despite their frequency, the natural history and biological behaviour of these lymphomas is poorly understood. In this study we ...
-
Article
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group Study
Fountzilas, George; Athanasiades, A.; Giannakakis, T.; Briassoulis, E. Ch; Bafaloukos, Dimitrios; Kalogera-Fountzila, Anna; Onienaoum, A.; Kalofonos, H. P.; Pectasides, Dimitrios; Andreopoulou, E.; Bamia, C.; Kosmidis, Paraskevas A.; Pavlidis, Nicholas; Skarlos, Dimosthenis V. (1997)Purpose: To evaluate the impact on the response rate in patients with advanced breast cancer (ABC) of the doubling of the dose intensity (DI) of epirubicin monotherapy. Patients and methods: From January 1991 until April ...
-
Article
Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer
Andreopoulou, E.; Andreopoulos, D.; Adamidis, K.; Fountzila-Kalogera, A.; Fountzilas, George; Dimopoulos, M. A.; Aravantinos, Gerasimos; Zamboglou, N.; Baltas, D.; Pavlidis, Nicholas (2002)Background: The usefulness of tumor volumetry in ovarian epithelial cancer has never been intensively investigated. The aim of the present study was to determine the value of quantitative analysis of tumor volume as a ...